Spirulina platensis improves mitochondrial function impaired by elevated oxidative stress in adipose-derived mesenchymal stromal cells (ASCs) and intestinal epithelial cells (IECs), and enhances insulin sensitivity in Equine Metabolic Syndrome (EMS) horses

Marine Drugs

Volumn 15, Issue 8, 2017, Pages

  Nawrocka, Daria ^a   Kornicka, Katarzyna ^a,b   Śmieszek, Agnieszka ^a   Marycz, Krzysztof ^a,b  

^a WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^b WROCLAW RESEARCH CENTRE EIT   (Poland)

Author keywords

Equine metabolic syndrome; Inflammation; Insulin resistance; Intestinal epithelial cells; Mesenchymal stromal cells; Oxidative stress; Spirulina platensis

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; NITRIC OXIDE; PHYCOCYANIN; PROTEIN P53; SPIRULINA EXTRACT; TUMOR NECROSIS FACTOR;

ADIPOSE DERIVED MESENCHYMAL STROMAL CELL; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; ENDOCRINE DISEASE; EQUINE METABOLIC SYNDROME; FEMALE; HORSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE EPITHELIUM CELL; MALE; MESENCHYMAL STROMA CELL; MITOCHONDRIAL DYNAMICS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; SENESCENCE; WEIGHT REDUCTION; ADIPOSE TISSUE; ANIMAL; CYTOLOGY; EPITHELIUM CELL; INTESTINE; METABOLIC SYNDROME X; METABOLISM; MITOCHONDRION; OBESITY; SPIRULINA;

ADIPOSE TISSUE; ANIMALS; EPITHELIAL CELLS; HORSES; INSULIN RESISTANCE; INTESTINES; MESENCHYMAL STROMAL CELLS; METABOLIC SYNDROME; MITOCHONDRIA; OBESITY; OXIDATIVE STRESS; SPIRULINA;

EID: 85029726134     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md15080237     Document Type: Article

References (78)

1. Frank, N. Equine metabolic syndrome. Vet. Clin. N. Am. Equine Pract. 2011, 27, 73–92. [CrossRef] [PubMed]
2. Monteiro, R.; Azevedo, I. Chronic inflammation in obesity and the metabolic syndrome. Mediat. Inflamm. 2010, 2010, 289645. [CrossRef] [PubMed]
3. Marycz, K.; Kornicka, K.; Basinska, K.; Czyrek, A. Equine Metabolic Syndrome affects viability, senescence, and stress factors of equine adipose-derived mesenchymal stromal stem cells: New insight into EqASCs isolated from EMS horses in the context of their aging. Oxid. Med. Cell. Longev. 2015, 2016, e4710326. [CrossRef] [PubMed]
4. Chaudhari, N.; Talwar, P.; Parimisetty, A.; Lefebvre D’Hellencourt, C.; Ravanan, P. A molecular web: Endoplasmic reticulum stress, inflammation, and oxidative stress. Front. Cell. Neurosci. 2014, 8, 213. [CrossRef] [PubMed]
5. Cao, S.S.; Kaufman, R.J. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid. Redox Signal. 2014, 21, 396–413. [CrossRef] [PubMed]
6. Ding, S.; Lund, P.K. Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14, 328–333. [CrossRef] [PubMed]
7. Kim, K.-A.; Gu, W.; Lee, I.-A.; Joh, E.-H.; Kim, D.-H. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE 2012, 7, e47713. [CrossRef] [PubMed]
8. Peterson, L.W.; Artis, D. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 2014, 14, 141–153. [CrossRef] [PubMed]
9. Huang, C.-J.; McAllister, M.J.; Slusher, A.L.; Webb, H.E.; Mock, J.T.; Acevedo, E.O. Obesity-related oxidative sstress: The impact of physical activity and diet manipulation. Sports Med. Open 2015, 1, 32. [CrossRef] [PubMed]
10. Tchkonia, T.; Morbeck, D.E.; von Zglinicki, T.; van Deursen, J.; Lustgarten, J.; Scrable, H.; Khosla, S.; Jensen, M.D.; Kirkland, J.L. Fat tissue, aging, and cellular senescence. Aging Cell 2010, 9, 667–684. [CrossRef] [PubMed]
11. Al-Dhabi, N.A.; Valan Arasu, M. Quantification of phytochemicals from commercial Spirulina products and their antioxidant activities. Evid. Based Complement. Altern. Med. 2016, 2016, e7631864. [CrossRef] [PubMed]
12. Deng, R.; Chow, T.-J. Hypolipidemic, antioxidant and antiinflammatory activities of microalgae Spirulina. Cardiovasc. Ther. 2010, 28, e33–e45. [CrossRef] [PubMed]
13. Pak, W.; Takayama, F.; Mine, M.; Nakamoto, K.; Kodo, Y.; Mankura, M.; Egashira, T.; Kawasaki, H.; Mori, A. Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis. J. Clin. Biochem. Nutr. 2012, 51, 227–234. [CrossRef] [PubMed]
14. Wu, Q.; Liu, L.; Miron, A.; Klímová, B.; Wan, D.; Kuča, K. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: An overview. Arch. Toxicol. 2016, 90, 1817–1840. [CrossRef] [PubMed]
15. Folch, J.; Lees, M.; Sloane Stanley, G.H.; Klímová, B.; Wan, D.; Kuča, K. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497–509. [PubMed]
16. Davidson, I. Hydrolysis of samples for amino acid analysis. Methods Mol. Biol. 1997, 64, 119–129. [PubMed]
17. Moraes, C.C.; Sala, L.; Cerveira, G.P.; Kalil, S.J. C-phycocyanin extraction from Spirulina platensis wet biomass. Braz. J. Chem. Eng. 2011, 28, 45–49. [CrossRef]
18. Horváth, H.; Kovács, A.W.; Riddick, C.; Présing, M. Extraction methods for phycocyanin determination in freshwater filamentous cyanobacteria and their application in a shallow lake. Eur. J. Phycol. 2013, 48, 278–286. [CrossRef]
19. Keller, T.; Shewager, H. Air pollution and ascorbic acid. Eur. J. For. Pathol. 1997, 7, 338–350. [CrossRef]
20. Basinska, K.; Marycz, K.; Śmieszek, A.; Nicpoń, J. The production and distribution of IL-6 and TNF-α in subcutaneous adipose tissue and their correlation with serum concentrations in Welsh ponies with equine metabolic syndrome. J. Vet. Sci. 2015, 16, 113–120. [CrossRef] [PubMed]
21. Grzesiak, J.; Marycz, K.; Wrzeszcz, K.; Czogała, J. Isolation and morphological characterization of ovine adipose-derived mesenchymal stem cells in culture. Int. J. Stem Cells 2011, 4, 99–104. [CrossRef] [PubMed]
22. Marycz, K.; Śmieszek, A.; Grzesiak, J.; Donesz-Sikorska, A.; Krzak-Roś, J. Application of bone marrow and adipose-derived mesenchymal stem cells for testing the biocompatibility of metal-based biomaterials functionalized with ascorbic acid. Biomed. Mater. 2013, 8, 065004. [CrossRef] [PubMed]
23. Maredziak, M.; Marycz, K.; Tomaszewski, K.A.; Kornicka, K.; Henry, B.M. The Influence of Aging on the Regenerative Potential of Human Adipose Derived Mesenchymal Stem Cells. Stem Cells Int. 2016, 2152435. [CrossRef] [PubMed]
24. Ray, A.; Dittel, B.N. Isolation of mouse peritoneal cavity cells. J. Vis. Exp. 2010, 35, 1488. [CrossRef] [PubMed]
25. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162, 156–159. [CrossRef]
26. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.J.; Keating, A.; Prockop, D.J.; Horwitz, E.M. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8, 315–317. [CrossRef] [PubMed]
27. Lin, C.-S.; Xin, Z.-C.; Dai, J.; Lue, T.F. Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges. Histol. Histopathol. 2013, 28, 1109–1116. [PubMed]
28. Kuilman, T.; Michaloglou, C.; Mooi, W.J.; Peeper, D.S. The essence of senescence. Genes Dev. 2010, 24, 2463–2479. [CrossRef] [PubMed]
29. Campisi, J.; D’Adda di Fagagna, F. Cellular senescence: When bad things happen to good cells. Nat. Rev. Mol. Cell. Biol. 2007, 8, 729–740. [CrossRef] [PubMed]
30. Tsujimoto, Y.; Shimizu, S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis Int. J. Program. Cell Death 2007, 12, 835–840. [CrossRef] [PubMed]
31. De Pablo-Latorre, R.; Saide, A.; Polishhuck, E.V.; Nusco, E.; Fraldi, A.; Ballabio, A. Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases. Hum. Mol. Genet. 2012, 21, 1770–1781. [CrossRef] [PubMed]
32. Zhang, X.; Goncalves, R.; Mosser, D.M. The Isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 2008. [CrossRef]
33. Davies, L.C.; Jenkins, S.J.; Allen, J.E.; Taylor, P.R. Tissue-resident macrophages. Nat. Immunol. 2013, 14, 986–995. [CrossRef] [PubMed]
34. Mosser, D.M.; Edwards, J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8, 958–969. [CrossRef] [PubMed]
35. Jung, U.J.; Choi, M.-S. Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int. J. Mol. Sci. 2014, 15, 6184–6223. [CrossRef] [PubMed]
36. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 2004, 114, 1752–1761. [CrossRef] [PubMed]
37. Xie, F.; Sun, S.; Xu, A.; Zheng, S.; Xue, M.; Wu, P.; Zeng, J.H.; Bai, L. Advanced oxidation protein products induce intestine epithelial cell death through a redox-dependent, c-jun N-terminal kinase and poly (ADP-ribose) polymerase-1-mediated pathway. Cell Death Dis. 2014, 5, e1006. [CrossRef] [PubMed]
38. Belay, A.; Ota, Y.; Miyakawa, K.; Shimamatsu, H. Current knowledge on potential health benefits of Spirulina. J. Appl. Phycol. 1993, 5, 235–241. [CrossRef]
39. Ramadan, M.F.; Asker, M.M.S.; Ibrahim, Z.K. Functional bioactive compounds and biological activities of Spirulina platensis lipids. Czech J. Food Sci. 2008, 26, 211–222.
40. Sanberg, C.D.; Bickford, P.C.; Sanberg, P.R.; Tan, J.; Shytle, R.D. Compounds for Stimulating Stem Cell Proliferation Including Spirulina. U.S. Patent 20,080,085,330 A1, 10 April 2008. Available online: http://www.google.com/patents/US20080085330 (accessed on 4 January 2017).
41. Deo, S.K.; Pandey, R.; Jha, S.K.; Singh, J.; Sodhi, K.S. Spirulina: The single cell protein. IAJP 2014, 4, 2211–2217.
42. Chu, W.-L.; Lim, Y.-W.; Radhakrishnan, A.K.; Lim, P.-E. Protective effect of aqueous extract from Spirulina platensis against cell death induced by free radicals. BMC Complement. Altern. Med. 2010, 10, 53. [CrossRef] [PubMed]
43. Li, X.-L.; Xu, G.; Chen, T.; Wong, Y.-S.; Zhao, H.-L.; Fan, R.-R.; Gu, X.-M.; Tong, P.C.Y.; Chan, J.C.N. Phycocyanin protects INS-1E pancreatic beta cells against human islet amyloid polypeptide-induced apoptosis through attenuating oxidative stress and modulating JNK and p38 mitogen-activated protein kinase pathways. Int. J. Biochem. Cell Biol. 2009, 41, 1526–1535. [CrossRef] [PubMed]
44. Ismail, M.F.; Ali, D.A.; Fernando, A.; Abdraboh, M.E.; Gaur, R.L.; Ibrahim, W.M.; Raj, M.H.G.; Ouhtit, A. Chemoprevention of rat liver toxicity and carcinogenesis by Spirulina. Int. J. Biol. Sci. 2009, 5, 377–387. [CrossRef] [PubMed]
45. Gu, Z.; Jiang, J.; Tan, W.; Xia, Y.; Cao, H.; Meng, Y.; Da, Z.; Liu, H.; Cheng, C. p53/p21 pathway involved in mediating cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients. Clin. Dev. Immunol. 2013, 2013, 134243. [CrossRef] [PubMed]
46. Armesilla-Diaz, A.; Elvira, G.; Silva, A. p53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells. Exp. Cell Res. 2009, 315, 3598–3610. [CrossRef] [PubMed]
47. Kamble, S.P.; Gaikar, R.B.; Padalia, R.B.; Shinde, K.D. Extraction and purification of C-phycocyanin from dry Spirulina powder and evaluating its antioxidant, anticoagulation and prevention of DNA damage activity. J. Appl. Pharm. Sci. 2013, 3, 149–153.
48. Linjawi, S.A. Protective effect of Spirulina against mitomycin C-Induced genotoxic damage in male rats. J. Am. Sci. 2011, 7, 922–931.
49. Jürgensmeier, J.M.; Xie, Z.; Deveraux, Q.; Ellerby, L.; Bredesen, D.; Reed, J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 1998, 95, 4997–5002. [CrossRef] [PubMed]
50. Finucane, D.M.; Bossy-Wetzel, E.; Waterhouse, N.J.; Cotter, T.G.; Green, D.R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem. 1999, 274, 2225–2233. [CrossRef] [PubMed]
51. Narendra, D.; Walker, J.E.; Youle, R. Mitochondrial quality control mediated by PINK1 and Parkin: Links to Parkinsonism. Cold Spring Harb. Perspect. Biol. 2012, 4, a011338. [CrossRef] [PubMed]
52. Jin, S.M.; Youle, R.J. PINK1- and Parkin-mediated mitophagy at a glance. J. Cell Sci. 2012, 125, 795–799. [CrossRef] [PubMed]
53. Wu, W.; Xu, H.; Wang, Z.; Mao, Y.; Yuan, L.; Luo, W.; Cui, Z.; Cui, T.; Wang, L.; Shen, Y. PINK1-Parkin-mediated mitophagy protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury. PLoS ONE 2015, 10, e0132499. [CrossRef] [PubMed]
54. Lee, S.H.; Du, J.; Stitham, J.; Atteya, G.; Lee, S.; Xiang, Y.; Wang, D.; Jin, Y.; Leslie, K.L.; Spollett, G.; et al. Inducing mitophagy in diabetic platelets protects against severe oxidative stress. EMBO Mol. Med. 2016, 8, 779–795. [CrossRef] [PubMed]
55. Marycz, K.; Kornicka, K.; Grzesiak, J.; Smieszek, A.; Szlapka, J. Macroautophagy and selective mitophagy ameliorate chondrogenic differentiation potential in adipose stem cells of equine metabolic syndrome: New findings in the field of progenitor cells differentiation. Oxid. Med. Cell. Longev. 2016, 2016, e3718468. [CrossRef] [PubMed]
56. Marycz, K.; Kornicka, K.; Marędziak, M.; Golonka, P.; Nicpoń, J. Equine metabolic syndrome impairs adipose stem cells osteogenic differentiation by predominance of autophagy over selective mitophagy. J. Cell. Mol. Med. 2016, 20, 2384–2404. [CrossRef] [PubMed]
57. Rani, V.; Deep, G.; Singh, R.K.; Palle, K.; Yadav, U.C.S. Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sci. 2016, 148, 183–193. [CrossRef] [PubMed]
58. Roberts, C.K.; Sindhu, K.K. Oxidative stress and metabolic syndrome. Life Sci. 2009, 84, 705–712. [CrossRef] [PubMed]
59. Uttara, B.; Singh, A.V.; Zamboni, P.; Mahajan, R. Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7, 65–74. [CrossRef] [PubMed]
60. Turrens, J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552, 335–344. [CrossRef] [PubMed]
61. Selivanov, V.A.; Votyakova, T.V.; Pivtoraiko, V.N.; Zeak, J.; Sukhomlin, T.; Trucco, M.; Roca, J.; Cascante, M. Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Comput. Biol. 2011, 7, e1001115. [CrossRef] [PubMed]
62. Liu, B.; Chen, Y.; St. Clair, D.K. ROS and p53: Versatile partnership. Free Radic. Biol. Med. 2008, 44, 1529–1535. [CrossRef] [PubMed]
63. Wu, L.; Guo, R.; Hui, L.; Ye, Y.; Xiang, J.; Wan, C.; Zou, M.; Ma, R.; Sun, X.; Yang, S.; et al. Stanniocalcin-1 protects bovine intestinal epithelial cells from oxidative stress-induced damage. J. Vet. Sci. 2014, 15, 475–483. [CrossRef] [PubMed]
64. Wiseman, H.; Halliwell, B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem. J. 1996, 313, 17–29. [CrossRef] [PubMed]
65. Datta, K.; Suman, S.; Kallakury, B.V.S.; Fornace, A.J. Exposure to heavy ion radiation induces persistent oxidative stress in mouse intestine. PLoS ONE 2012, 7, e42224. [CrossRef] [PubMed]
66. Denu, R.A.; Hematti, P. Effects of oxidative stress on mesenchymal stem cell biology. Oxid. Med. Cell. Longev. 2016, 2016, e2989076. [CrossRef] [PubMed]
67. Santoyo, S.; Herrero, M.; Senorans, F.J.; Cifuentes, A.; Ibáñez, E.; Jaime, L. Functional characterization of pressurized liquid extracts of Spirulina platensis. Eur. Food Res. Technol. 2006, 224, 75–81. [CrossRef]
68. Dartsch, P.C. Antioxidant potential of selected Spirulina platensis preparations. Phytother. Res. 2008, 22, 627–633. [CrossRef] [PubMed]
69. Romay, C.; Armesto, J.; Remirez, D.; González, R.; Ledon, N.; García, I. Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflamm. Res. 1998, 47, 36–41. [CrossRef] [PubMed]
70. Romay, C.; Ledón, N.; González, R. Further studies on anti-inflammatory activity of phycocyanin in some animal models of inflammation. Inflamm. Res. 1998, 47, 334–338. [CrossRef] [PubMed]
71. Esposito, K.; Giugliano, D. The metabolic syndrome and inflammation: Association or causation? Nutr. Metab. Cardiovasc. Dis. 2004, 14, 228–232. [CrossRef]
72. Joventino, I.P.; Alves, H.G.R.; Neves, L.C.; Pinheiro-Joventino, F.; Leal, L.K.A.M.; Neves, S.A.; et al. The microalga Spirulina platensis presents anti-inflammatory action as well as hypoglycemic and hypolipidemic properties in diabetic rats. J. Complement. Integr. Med. 2012, 9, 17. [CrossRef] [PubMed]
73. Pham, T.X.; Park, Y.-K.; Lee, J.-Y. Anti-inflammatory effects of Spirulina platensis extract via the modulation of histone deacetylases. Nutrients 2016, 8, 381. [CrossRef] [PubMed]
74. Pham, T.X.; Lee, J.-Y. The anti-inflammatory effects of Spirulina platensis extract are mediated, in part, through the induction of an endotoxin tolerance-like mechanism. FASEB J. 2016, 30 (Suppl. 916.15).
75. Quader, S.H.; Islam, S.U.; Saifullah, A.; Majumder, F.U.; Hannan, J. In-vivo studies of the anti-inflammatory effects of Spirulina platensis. Pharma Innov. 2013, 2, 70–80.
76. Abdel-Daim, M.M.; Farouk, S.M.; Madkour, F.F.; Azab, S.S. Anti-inflammatory and immunomodulatory effects of Spirulina platensis in comparison to Dunaliella salina in acetic acid-induced rat experimental colitis. Immunopharmacol. Immunotoxicol. 2015, 37, 126–139. [CrossRef] [PubMed]
77. Kumar, N.; Singh, S.; Patro, N.; Patro, I. Evaluation of protective efficacy of Spirulina platensis against collagen-induced arthritis in rats. Inflammopharmacology 2009, 17, 181–190. [CrossRef] [PubMed]
78. Parikh, P.; Mani, U.; Iyer, U. Role of Spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus. J. Med. Food 2001, 4, 193–199. [CrossRef] [PubMed]